NovaBridge Biosciences (NBP) Goodwill & Intangibles (2018 - 2023)

NovaBridge Biosciences (NBP) has 6 years of Goodwill & Intangibles data on file, last reported at $16.4 million in Q4 2023.

• Quarterly Goodwill & Intangibles fell 58.55% year-over-year to $16.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $16.4 million (down 58.55% YoY) and the FY2023 annual result came in at $16.7 million, down 99.96% from the prior year.
• Goodwill & Intangibles declined to $16.4 million in Q4 2023 per NBP's latest filing, from $40.1 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $44.1 billion in Q4 2021 and bottomed at $16.4 million in Q4 2023.
• The 5-year median for Goodwill & Intangibles is $42.7 million (2020), against an average of $4.5 billion.
• The widest annual swing landed in 2021, when Goodwill & Intangibles surged 103270.82%; it then slumped 99.91% in 2022.
• Tracing NBP's Goodwill & Intangibles over 5 years: stood at $44.2 million in 2019, then declined by 3.35% to $42.7 million in 2020, then surged by 103270.82% to $44.1 billion in 2021, then sank by 99.91% to $39.6 million in 2022, then tumbled by 58.55% to $16.4 million in 2023.
• Per Business Quant, the three latest NBP Goodwill & Intangibles figures stand at $16.4 million (Q4 2023), $40.1 million (Q2 2023), and $39.6 million (Q4 2022).

Peer Comparison